2026 BioTech Breakthrough Honors VectorBuilder With “Overall CGT Solution Provider of the Year”

Annual awards program recognizes innovation in life sciences and biotechnology worldwide

CHICAGO--(BUSINESS WIRE)--VectorBuilder, a global leader in gene delivery technologies, today announced it has been named “Overall CGT Solution Provider of the Year” in the sixth annual BioTech Breakthrough Awards, recognizing innovation across the global life sciences and biotechnology industries.

VectorBuilder integrates vector design, cloning, packaging, optimization, process development, and GMP manufacturing within one organization. Through its online Vector Studio, researchers can design and order custom vectors, then access viral and non-viral vector production, specialized CRO services, vector engineering, and GMP manufacturing as their programs advance.

This integrated approach enables therapy developers to consider vector performance, manufacturability, and scalability earlier in development, supporting a more connected path from research through clinical translation.

VectorBuilder is also advancing technologies addressing persistent gene delivery challenges. Its DeepCap platform combines machine learning, rational design, and large-scale AAV sequence screening to engineer capsids with improved tissue targeting and transduction characteristics. Its miniVec plasmid system eliminates antibiotic-resistance genes and is designed to improve manufacturability and functionality across genetic medicine applications.

“We built our gene delivery platform around a simple but consequential idea: the vector designed at the beginning of a cell or gene therapy program should be developed with its path to the clinic in mind,” said Dr. Kristofer Mussar, Chief Operating Officer of VectorBuilder. “Combining scientific, engineering, and manufacturing expertise allows us to support that journey. We’re honored to receive this recognition from BioTech Breakthrough.”

The BioTech Breakthrough Awards recognize companies and technologies advancing biotechnology, from genomics and gene editing to precision medicine and biomanufacturing.

“Early vector decisions can have downstream consequences for performance, manufacturability, safety, and regulatory strategy,” said Bryan Vaughn, Managing Director, BioTech Breakthrough. “VectorBuilder brings together accessible vector design, specialized gene delivery innovation, translational expertise, and GMP manufacturing, supporting researchers and therapy developers from initial design through clinical development. We’re pleased to recognize VectorBuilder as ‘Overall CGT Solution Provider of the Year.’”

About VectorBuilder

VectorBuilder is a global leader in gene delivery technologies. As a trusted partner in thousands of labs and biotech/pharma companies around the world, VectorBuilder is a one-stop shop for the design, development, and optimization of gene delivery solutions from basic research to clinical applications. Its award-winning Vector Studio is a transformative innovation that allows researchers to easily design and order custom vectors online, freeing them from the tedious work of cloning and packaging vectors in the lab. The global company boasts high-throughput vector production capacity, vast vector and component inventories, one-on-one CRO solutions that include advanced AAV capsid engineering capabilities, and state-of-the-art GMP manufacturing facilities. With leading R&D and CDMO capabilities, the VectorBuilder team strives to provide the most effective gene-delivery solutions and develop innovative tools for life sciences research and genetic medicine.

About BioTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the BioTech Breakthrough Awards program is devoted to honoring excellence in life science and biotechnology solutions, services and companies. The BioTech Breakthrough Awards provide public recognition for the achievements of biotechnology companies and products in categories including BioPharma, Genomics, Therapeutics, Immunology, Food Science and BioAgriculture, and more. For more information visit BioTechBreakthroughAwards.com

Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.